Literature DB >> 12420628

[Alkaline phosphatase isoenzymes in the serum of patients with renal insufficiency].

M R Sánchez Navarro1, M E Fernández-Conde, S Blanco Martín, C Samaniego.   

Abstract

OBJECTIVE: The aim of this study was to test the utility of serum alkaline phosphatase isoenzymes determination from patients with renal insufficiency.
MATERIAL AND METHODS: Serum levels of alkaline phosphatase isoenzymes were determined in a group of 58 patients: 22 of them suffering acute renal insufficiency (ARI) and 36 with chronic renal failure (CRF) undergoing regular hemodialysis, results obtained were compared from a population of 30 healthy adults. Intestinal, bone, liver, macromolecular and intestinal variant isoenzymes, were separated by electrophoresis on agarose gel and quantified using a densitometer.
RESULTS: Were found a significant increase the total alkaline phosphatase activity in both pathologic groups (p < 0.05 in ARI and p < 0.01 in CRF). Isoenzymatic profiles showed: increase of the bone fraction (p < 0.05 in ARI and p < 0.001 in CRF), decrease of the liver isoenzyme (p < 0.001) in both groups, macromolecular fraction elevated in acute patients (p < 0.05) and a significant increase of the intestinal and intestinal variant isoenzyme in the chronic patients (p < 0.001).
CONCLUSION: The renal insufficiency modified the normal distribution of alkaline phosphatase isoenzymes and the study of their serum levels could be an effective non-invasive marker, for the evaluation of bone disease and intestinal disorders associated with renal failure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12420628

Source DB:  PubMed          Journal:  An Med Interna        ISSN: 0212-7199


  2 in total

1.  Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients.

Authors:  Ronney Shantouf; Csaba P Kovesdy; Youngmee Kim; Naser Ahmadi; Amanda Luna; Claudia Luna; Mehdi Rambod; Allen R Nissenson; Matthew J Budoff; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 8.237

2.  Embelia ribes extract reduces high fat diet and low dose streptozotocin-induced diabetic nephrotoxicity in rats.

Authors:  Hemantkumar Somabhai Chaudhari; Uma Bhandari; Geetika Khanna
Journal:  EXCLI J       Date:  2013-09-24       Impact factor: 4.068

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.